The OB-WELL Project, a Randomized Controlled Trial of an Internet-Based Self-Help System for Psychological Support in Obesity

March 12, 2026 updated by: Gianluca Castelnuovo, Catholic University of the Sacred Heart

The OB-WELL Project: Study Protocol for a Three-Arm Randomized Controlled Trial of an Internet-Based Self-Help System for Psychological Support in Obesity

Objective: This study aims to evaluate the feasibility and effectiveness of the OB-WELL program, an internet-based self-help intervention grounded in the principles of Cognitive Behavioral Therapy (CBT) and Brief Strategic Therapy (BST), designed to promote psychological well-being among individuals with obesity from the general Italian population. Methods: A three-arm randomized controlled trial with individual-level random allocation will be conducted to compare two active intervention formats - CBT and BST - with a waiting list (WL) control condition. The intervention will last six weeks and will consist of five online self-help modules followed by one individual synchronous session. Selected psychological outcomes will be assessed at baseline and immediately post-intervention (after 6 weeks). Participants in the experimental groups will also complete follow-up assessments at 3, 6, and 12 months after treatment termination.

Expected results and conclusions: Both active interventions are expected to show greater improvements immediately post-treatment compared to the waitlist (WL) condition, and these effects are anticipated to be maintained over time. It is further hypothesized that the BST condition will demonstrate greater stability of psychological outcomes at follow-up compared to CBT.

Study Overview

Detailed Description

INTRODUCTION Clinical obesity is defined as a chronic, multifactorial disease characterized by excessive adipose tissue accumulation associated with measurable dysfunction in organ and tissue systems and/or clinically meaningful, age-adjusted impairments in daily functioning. Obesity exerts systemic effects across multiple physiological domains and significantly increases the risk of severe comorbidities, including type 2 diabetes, cardiovascular and cerebrovascular diseases, hypertension, dyslipidemia, several malignancies, osteoarthritis, reproductive disorders, and premature mortality.

Beyond its clinical burden, obesity represents a rapidly escalating global public health challenge. Epidemiological projections indicate a substantial increase in prevalence over the past decades, with profound implications for healthcare sustainability and resource allocation worldwide.

In parallel, robust evidence demonstrates that obesity is associated with elevated levels of psychological distress, including higher rates of depression and anxiety relative to normal-weight populations. Psychological factors-such as affective symptoms, maladaptive eating behaviors, perceived stigma, discrimination, and chronic stress-contribute not only to onset but also to the persistence and progression of obesity. Accordingly, contemporary clinical guidelines increasingly recommend the integration of structured psychological interventions within multidisciplinary obesity care pathways.

Cognitive-Behavioral Therapy (CBT) has demonstrated efficacy in improving both weight-related and psychological outcomes through techniques such as cognitive restructuring, behavioral activation, goal setting, action planning, and relaxation training. However, although short-term benefits are well established, evidence suggests that partial weight regain and attenuation of psychological gains may occur following treatment discontinuation, highlighting challenges related to long-term adherence and maintenance. Structural barriers-including high treatment costs, geographic inaccessibility, and limited continuity of care-further constrain the scalability of traditional face-to-face interventions.

These limitations underscore the need for technology-enabled, scalable, and sustainable intervention models. Digital and telemedicine-based psychological interventions have emerged as promising solutions to enhance accessibility, optimize cost-effectiveness, and support longitudinal behavioral regulation in individuals with obesity.

Systematic evaluations of digital interventions-including web-based platforms, mobile applications, telehealth systems, virtual reality (VR), and artificial intelligence (AI)-supported tools suggest that cognitive-behavioral and third-wave approaches (e.g., ACT, mindfulness-based interventions) are associated with improvements in psychological distress and maladaptive eating behaviors. Nevertheless, long-term outcome stability remains insufficiently established, with limited follow-up durations and inconsistent maintenance of treatment gains.

Alternative therapeutic frameworks may therefore warrant systematic investigation to enhance the durability of effects. Brief Strategic Therapy (BST) represents a solution-focused, systems-oriented model aimed at disrupting maladaptive and repetitive problem-maintaining strategies through targeted heuristic interventions.

Preliminary evidence from the STRATOB randomized controlled trial (RCT) suggests that BST, particularly when integrated with telecare follow-up, may enhance maintenance of psychological improvements compared to CBT, although weight outcomes were comparable across conditions. This study investigates the feasibility and effectiveness of OB-WELL, a web-based self-help intervention developed to support psychological well-being among individuals with obesity in the Italian general population. The system integrates structured therapeutic content based on either CBT or BST principles within a scalable digital delivery framework.

A three-arm RCT design is employed to compare two active internet-based intervention modules (CBT-based and BST-based) with a WL control condition. Self-reported outcome measures will be collected at baseline (T0), immediately post-intervention (6 weeks), and at 3-, 6-, and 12-month follow-ups for participants in the active conditions.

It is hypothesized that both active digital interventions will yield significantly greater improvements in psychological outcomes compared to the WL condition at post-treatment. Furthermore, treatment effects are expected to be sustained over time within the experimental groups. It is additionally hypothesized that the BST-based intervention will demonstrate greater longitudinal stability of psychological outcomes at follow-up relative to the CBT-based condition, suggesting enhanced durability of effects within a digital self-help environment.

METHODS Sample Size Calculation An a priori power analysis (F tests) conducted using G*Power software (version 3.1.9.7) indicated that 168 participants (56 per group) were required to achieve 95% power (α = .05, two-sided) to detect an interaction effect size = 0.25.

To account for potential attrition, a conservative dropout rate of 25% was assumed, consistent with previous research on internet-based self-help interventions, which has reported average dropout rates in the mid-20s across diverse populations. Accordingly, the target recruitment was increased to 224 participants, approximately 75 per group, to ensure sufficient statistical power after accounting for the expected loss to follow-up.

Procedure Participants will be recruited from the general population through a structured digital outreach strategy leveraging social media platforms (e.g., Facebook, Instagram, and Twitter) and online communities dedicated to obesity-related topics. Recruitment materials will provide standardized information regarding the study objectives, intervention characteristics, eligibility criteria, and participation procedures. They will include a secure hyperlink directing users to the study platform. As an initial screening step, participants will be asked to answer demographic questions and to complete the WSQ and the BES online. Within five days, they will attend a 30-minute semi-structured clinical interview conducted by a licensed clinical psychologist not involved in the study, further assessing eligibility and clarifying study procedures. Participants will be informed of the outcome via email within one week. In cases of exclusion, a brief explanation of the decision will be provided. Individuals presenting severe psychological distress will be encouraged to seek appropriate professional support.

Eligible participants will then be randomly allocated through an automated, computer-generated randomization procedure implemented within the Iterapi platform to one of three study arms: (1) CBT-based internet self-help intervention, (2) BST-based internet self-help intervention, or (3) WL control group. Participants assigned to the intervention arms will receive credentials granting direct access to the Iterapi platform, a secure digital platform previously used in psychological interventions. For ethical considerations, participants allocated to the WL control group will gain access to the intervention after the experimental groups have completed the 6-week treatment period.

The program comprises five structured online self-help modules, delivered in either a CBT-based or BST-based format. The modules are designed to address the following domains: (1) introduction to the intervention framework and definition of individualized objectives; (2) identification and restructuring of negative automatic thoughts; (3) recognition and regulation of emotions, with specific focus on emotional eating; (4) stress management and development of assertive communication skills; and (5) enhancement of motivation, problem-solving abilities, and self-efficacy. An additional synchronous video-meeting (Module 6) is conducted to consolidate acquired skills, support relapse prevention, and promote long-term maintenance of treatment gains.

The Iterapi platform will serve as the primary channel for communication between participants and mental health professionals, as well as for intervention delivery and collection of outcome measures.

Assessments for all participants will be administered at baseline and 6 weeks later (post-treatment). In addition, participants in the intervention groups will be followed up at 3, 6, and 12 months (follow-up). Throughout the intervention period, participants will receive weekly email notifications informing them of newly available materials on the platform. Participants who do not access the materials or fail to complete the recommended exercises will receive weekly reminders accompanied by brief motivational messages.

Although no adverse effects are anticipated, participants experiencing psychological discomfort may contact the study psychologist or consult the study coordinator at any time for clarification or further information. Participation is entirely voluntary, and enrolled individuals may withdraw from the study at any time without any consequences for current or future care.

Statistical Analysis Analyses will be conducted on an intention-to-treat (ITT) sample. Baseline comparability across the three conditions will be evaluated using chi-square tests for categorical variables and F tests for continuous variables. Continuous outcomes will be modeled using mixed-effects models with random intercepts and slopes for participants, and fixed effects for condition and repeated measures over time. Intervention effects will be indicated by significant condition × time interactions. Mixed-effects models allow the inclusion of all available data while accounting for missing values via maximum likelihood estimation. Significant overall effects will be followed by planned contrasts: first, pooling the two active interventions against the control condition, and then comparing the two active interventions directly. Statistical significance will be set at p = .05, and effect sizes will be calculated following Cohen's method. Reliable Change Indices will also be computed to assess clinically meaningful individual-level change. Statistical analyses will be conducted using SPSS software (version 31.0).

EXPECTED RESULTS Obesity represents one of the most relevant public health challenges worldwide, with a variety of adverse effects on mental and physical health. Access to psychological interventions addressing these associated psychological dimensions remains limited, highlighting the need for scalable and accessible treatment approaches.

This study aims to evaluate the efficacy of an internet-based self-help intervention designed to enhance emotional well-being, promote adaptive coping strategies, strengthen self-management skills, and improve weight-related outcomes in individuals with obesity.

We hypothesize that participants in both intervention groups will exhibit improved psychological outcomes compared with a WL control group at post-treatment. Furthermore, reductions are expected to be more pronounced among participants receiving BST relative to those receiving CBT. Direct comparison of the two intervention conditions will allow assessment of the added benefit of BST beyond the effects of the internet-based CBT intervention. Intervention usability will also be examined to guide further refinement of the program. Feasibility outcomes will be assessed using measures of program adherence, module completion rates, and participant retention throughout the intervention and follow-up periods. These indicators will provide valuable information on the acceptability, engagement, and potential sustainability of internet-based self-help interventions for individuals with obesity.

Limitations Several limitations of the study should be considered. First, participation requires sufficient internet access and basic digital literacy, potentially limiting inclusion of individuals with lower technological proficiency, particularly older adults. To address this, a preliminary usability assessment will be conducted before trial implementation to identify and mitigate platform-related barriers, with specific attention to non-digital-native users. Second, individuals with moderate to severe symptoms of mental disorders, such as clinically significant depressive symptoms, as well as those currently receiving psychological or psychopharmacological treatment, are excluded, which restricts the generalizability of the findings to the broader population experiencing loneliness. Third, the study design does not allow long-term comparison with the wait-list control, since the wait-list group is granted access to the intervention after a short delay to minimize withholding of support. Finally, as commonly observed in web-based self-help interventions, attrition rates may be higher than in face-to-face treatments. To mitigate this risk, participants will receive regular reminders and motivational messages to encourage ongoing engagement.

Study Type

Interventional

Enrollment (Estimated)

224

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 years or older;
  • Body Mass Index (BMI) ≥ 30 kg/m²; 3. Internet access;
  • Sufficient computer and internet literacy;
  • Fluent knowledge of the Italian language;
  • Provision of informed consent via the digital platform;
  • Presence of mild or subthreshold psychological or eating-related symptoms, as identified by the Web Screening Questionnaire (WSQ);
  • Presence of a score < 27 on the Binge Eating Scale (BES).

Exclusion Criteria:

  • Visual, auditory, or cognitive impairments that could limit effective interaction with the digital interface;
  • Diagnosis of severe psychiatric disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5);
  • Insufficient digital literacy or lack of stable internet connectivity;
  • Concurrent psychopharmacological treatment or ongoing psychological/psychotherapeutic intervention during the study period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBT intervention
Participants allocated to the CBT experimental group will be asked to complete one module per week (6 weeks), each based on the core principles of Cognitive Behavioral Therapy (CBT). The modules are designed to address the following domains: (1) introduction to the intervention framework and definition of individualized objectives; (2) identification and restructuring of negative automatic thoughts; (3) recognition and regulation of emotions, with specific focus on emotional eating; (4) stress management and development of assertive communication skills; and (5) enhancement of motivation, problem-solving abilities, and self-efficacy. An additional synchronous video-meeting (Module 6) is conducted to consolidate acquired skills, support relapse prevention, and promote long-term maintenance of treatment gains.
Participants allocated to the experimental group will be asked to complete one module per week, each based on the core principles of Cognitive Behavioral Therapy (CBT). The program comprises five structured online self-help modules, designed to address the following domains: (1) introduction to the intervention framework and definition of individualized objectives; (2) identification and restructuring of negative automatic thoughts; (3) recognition and regulation of emotions, with specific focus on emotional eating; (4) stress management and development of assertive communication skills; and (5) enhancement of motivation, problem-solving abilities, and self-efficacy. An additional synchronous video-meeting (Module 6) is conducted to consolidate acquired skills, support relapse prevention, and promote long-term maintenance of treatment gains.
Experimental: BST intervention
Participants allocated to the CBT experimental group will be asked to complete one module per week (6 weeks), each based on the core principles of Brief Strategic Therapy (BST). The modules are designed to address the following domains: (1) introduction to the intervention framework and definition of individualized objectives; (2) identification and restructuring of negative automatic thoughts; (3) recognition and regulation of emotions, with specific focus on emotional eating; (4) stress management and development of assertive communication skills; and (5) enhancement of motivation, problem-solving abilities, and self-efficacy. An additional synchronous video-meeting (Module 6) is conducted to consolidate acquired skills, support relapse prevention, and promote long-term maintenance of treatment gains.
Participants allocated to the experimental group will be asked to complete one module per week, each based on the core principles of Brief Strategic Therapy (BST). The program comprises five structured online self-help modules, designed to address the following domains: (1) introduction to the intervention framework and definition of individualized objectives; (2) identification and restructuring of negative automatic thoughts; (3) recognition and regulation of emotions, with specific focus on emotional eating; (4) stress management and development of assertive communication skills; and (5) enhancement of motivation, problem-solving abilities, and self-efficacy. An additional synchronous video-meeting (Module 6) is conducted to consolidate acquired skills, support relapse prevention, and promote long-term maintenance of treatment gains.
No Intervention: Waiting List
Participants allocated to the waiting list control group will not receive the intervention during the initial six-week study period. However, they will be granted full access to the treatment program after the six weeks have elapsed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General Psychological Distress
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The Clinical Outcomes in Routine Evaluation-10 (CORE-10) (La Tona et al., 2023) is a brief 10-item self-report measure assessing general psychological distress for routine outcome monitoring in clinical and research settings. It is a shortened version of the 34-item CORE-Outcome Measure (CORE-OM) and covers key domains of distress, including psychological problems, functioning, and risk to self. Items are rated on a 5-point Likert scale ranging from 0 (not at all) to 4 (most or all of the time), yielding a total score ranging from 0 to 40, with higher scores indicating greater psychological distress. Two items are positively worded and are reverse-scored.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stress
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The Perceived Stress Scale (PSS) (Mondo et al., 2021) is a 10-item self-report measure assessing the degree to which individuals perceive situations in their lives as stressful. Items are rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). After reversing items 4, 5, 7, and 8, total scores range from 0 to 40, with higher scores reflecting greater perceived stress.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
Emotional Regulation
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The Difficulties in Emotion Regulation Scale - 8 items (DERS-8) (Rossi et al., 2025) is a brief self-report measure assessing difficulties in emotion regulation. It includes 8 items rated on a 5-point Likert scale ranging from 1 (almost never) to 5 (almost always). The scale evaluates key aspects of emotional dysregulation, including lack of emotional clarity, difficulties in goal-directed behavior, impulse control difficulties, and limited access to effective emotion regulation strategies. Higher scores indicate greater difficulties in emotion regulation.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
Compulsive Eating Behaviors
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The Measure of Eating Compulsivity - Italian version (MEC10-IT) (Rossi et al., 2023) is a 10-item self-report questionnaire assessing compulsive eating behaviors within the food addiction framework. Items are rated on a 5-point Likert scale ranging from 0 (very untrue) to 4 (very true), with higher total scores indicating greater levels of eating compulsivity. The Italian version has demonstrated good internal consistency, construct validity, and adequate screening accuracy in both clinical and non-clinical samples.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
Anxiety
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The Generalized Anxiety Disorder 7-item scale (GAD-7) (Spitzer et al., 2006) is a 7-item self-report measure assessing the severity of generalized anxiety symptoms over the past two weeks. Items are rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day), yielding a total score between 0 and 21. According to established cut-off scores, values of 5, 10, and 15 indicate mild, moderate, and severe anxiety symptoms, respectively. The GAD-7 has demonstrated excellent reliability and validity and is widely used in both clinical practice and research settings.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
Depression
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The Patient Health Questionnaire-9 (PHQ-9) (Kroenke et al., 2001) is a 9-item self-report questionnaire assessing the presence and severity of depressive symptoms over the previous two weeks. Items are rated on a 4-point Likert scale (0 = not at all; 3 = nearly every day), yielding a total score ranging from 0 to 27, with higher scores indicating greater depressive symptom severity. Cut-off scores of 5, 10, 15, and 20 correspond to mild, moderate, moderately severe, and severe depressive symptoms, respectively. The PHQ-9 has demonstrated good reliability and validity and is widely used in both clinical and research settings.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
Self-Efficacy
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The General Self-Efficacy Scale (GSES) (Luszczynska et al., 2005) is a 10-item self-report measure assessing generalized beliefs in one's ability to cope with stressful or challenging situations. Items are rated on a 4-point Likert scale ranging from 1 (not at all true) to 4 (exactly true), yielding total scores from 10 to 40. Higher scores reflect greater perceived self-efficacy. The GSES has demonstrated good reliability and validity across diverse populations and cultural contexts and is widely used in both clinical and research settings.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
Well-Being
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The WHO-5 Well-Being Index (Topp et al., 2015), developed by the World Health Organization (World Health Organization (WHO), 1998), is a 5-item self-report measure assessing subjective psychological well-being over the past two weeks. Items are positively worded and rated on a 6-point Likert scale ranging from 0 (at no time) to 5 (all of the time), yielding a raw score from 0 to 25. In line with standard procedures, the total raw score is multiplied by four to obtain a final score ranging from 0 to 100, with higher scores indicating greater well-being.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
Eating Behavior
Time Frame: baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up
The Three-Factor Eating Questionnaire-Revised (TFEQ-R18) (Blandine De Lauzon et al., 2004) is an 18-item self-report questionnaire assessing three dimensions of eating behavior: cognitive restraint, uncontrolled eating, and emotional eating. Items are rated on a 4-point Likert scale, and subscale scores are typically transformed to a 0-100 scale. Higher scores reflect higher levels of the respective eating behavior dimension. The TFEQ-R18 has demonstrated good psychometric properties in both clinical and general population samples.
baseline, post-intervention (6 weeks), 3-, 6-, 12-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gianluca Castelnuovo, Catholic University of Sacred Heart of Milan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 15, 2026

Primary Completion (Estimated)

January 15, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 17, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

De-identified data may be available from the corresponding author upon reasonable request, in accordance with institutional and ethical regulations

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity (BMI > 35)

Clinical Trials on CBT Internet-based intervention

Subscribe